European Commission approves Benlysta for adult patients ... | 合法藥品大搜索

Read More

2021年1月14日 — To the Editor: Furie et al. (Sept. 17 issue)1 report the results of the Belimumab International Study in Lupus Nephritis (BLISSLN), a large, ... Read More

由 M Ward 著作 · 2020 · 被引用 3 次 — Belimumab as Add-on Therapy in Lupus Nephritis ... Nephritis, the most common serious manifestation of systemic lupus erythematosus (SLE), ... Read More

由 N Oliva-Damaso 著作 · 2021 — Belimumab is a human monoclonal antibody that inhibits the soluble form of a B-​cell survival factor known as BLyS or BAFF. BLyS levels are ... Read More

由 SJ Allison 著作 · 2020 — The BAFF-neutralizing antibody belimumab is approved for use in patients with SLE, but trials to date have excluded patients with acute, severe ... Read More

由 R Furie 著作 · 2020 · 被引用 80 次 — In this trial involving patients with active lupus nephritis, more patients who received belimumab plus standard therapy had a primary efficacy ... Read More

2021年5月5日 — Benlysta is the first biologic approved to treat lupus and lupus nephritis, representing a significant new treatment option for patients and ... Read More

2020年12月17日 — The FDA has approved belimumab in intravenous and subcutaneous formulations for the treatment of lupus nephritis in adult patients who are ... Read More